反应详情

A solution of 4-[4-(4-ethoxy-2-fluoro-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester (Example 43; 110 mg) in 20% trifluoroacetic acid/dichloromethane (5 mL) was stirred at room temperature for 3 hours. The solvent was removed to afford 4-(4-ethoxy-2-fluoro-phenoxy)-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidine trifluoroacetate salt (112 mg, 99%) which was used directly in the next step without further purification.

1. customThe solvent was removed